Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesDeferasirox pharmacokinetics in patients with adequate vs. inadequate response
Blood, 09/17/09
Chirnomas D et al. – Tens of thousands of transfusion–dependent (e.g., thalassemia) patients worldwide suffer from chronic iron–overload and its potentially fatal complications. The oral iron chelator, deferasirox became commercially available in many countries since 2006. Effective dosing regimens for inadequately responding patients to deferasirox must be determined.
Today in Pharmacokinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
U-500 Regular Insulin: Clinical Experience and Pharmacokinetics in Obese, Severely Insulin Resistant Type 2 Diabetic Patients
Diabetes Care, 11/16/09
The role of ceramide in major depressive disorder
European Archives of Psychiatry and Clinical Neuroscience, 11/12/09
Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas
Clinical Cancer Research, 11/20/09
Sponsor
Article Search
Sponsor